# NU-MED PLUS, INC. (NUMD) · Edgar & Edgarette company card

> Nu-Med Plus (NUMD) reported revenue of $0 million in FY2020, operating margin null against a -0.9% median for gold and silver ores, equity 83.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1543637 · fiscal year ended 2020-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NUMD) · [JSON](https://www.pops4.com/boards/company/NUMD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -Infinity%) |
| Net margin | -Infinity% |
| Operating cash flow | −$414,799 |
| Capital spending | — |
| Free cash flow | — |
| Cash | $188,506 |
| Long-term debt | — |
| Total assets | $557,135 |
| Total equity | $467,703 |
| Equity ÷ assets | 83.9% |
| Return on equity | -429.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -64.32 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · filed late annual report notice, late quarterly report notice in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$48K in FY2025)

## Edgarette's reading

Exposure: revenue $0K (FY2020). Experience: one year on record; operating margin null, up from null. Soundness: equity 83.9% of assets, return on equity -429.5%. Credibility: four or more audited years, reasonable weight. Against peers (10 filers, $50M+ revenue, its industry group): operating margin null against a -0.9% median.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1543637/000154363726000001/0001543637-26-000001-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-11-16 ([filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000792/0001575872-26-000792-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-07-10 ([filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000494/0001575872-26-000494-index.htm))

## Recent filings

- DEF 14A · filed 2026-11-13 · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000788/0001575872-26-000788-index.htm)
- 8-K · filed 2026-11-02 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 5.08 Shareholder Nominations Pursuant to Rule 14a-11; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000755/0001575872-26-000755-index.htm)
- 8-K · filed 2026-10-20 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/0001575872-26-000709-index.htm)
- 8-K · filed 2026-08-25 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000609/0001575872-26-000609-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000575/0001575872-26-000575-index.htm)
- 8-K · filed 2026-07-10 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modifications to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure or Election of Directors; Appointment of Officers; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1543637/000157587226000494/0001575872-26-000494-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001543637.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1543637

## Cite

POPS4, Edgar & Edgarette: NU-MED PLUS, INC. (NUMD) company card, from the company's own SEC filings, accessed 2026-11-20, https://www.pops4.com/boards/company/NUMD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Its latest audited year is FY2025, which reports no revenue; the revenue figures and the range here are from FY2020, its last year with revenue on record. Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

